Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Stratus Pharmaceuticals Inc
EIR
•Stratus Pharmaceuticals Inc•December 8, 2014

Stratus Pharmaceuticals Inc – FDA EIR, Dec 8, 2014

Record Details

An FDA for-cause cGMP inspection of Stratus Pharmaceuticals Inc., an own-label distributor of prescription and OTC drugs in Miami, FL, was conducted from November 18 to December 8, 2014. This inspection was initiated as a follow-up to significant cGMP deficiencies found at their co-owned contract manufacturer, Sonar Products Inc. The inspection identified several critical violations, documented on an FDA-483. Stratus Pharmaceuticals demonstrated inadequate written procedures for complaint handling, notably failing to forward 1,362 product quality complaints (including over 1,000 for defective Hypercare 20% Solution applicators) to its contract manufacturer for investigation and trending. The firm also lacked a defined quality control unit with documented responsibilities for critical quality activities like label approval and product release. Procedures for reporting serious adverse drug experiences and documentation of employee cGMP training were also deficient. Furthermore, a major verbal observation highlighted the unapproved status of all Stratus's prescription drug products, which were being marketed without required FDA drug applications. Labeling deficiencies were also noted for certain multi-vitamin products. Management, represented by President Alberto Hoyo, promised corrective actions, a written response within 15 business days, and outlined plans to engage external firms to achieve cGMP compliance, conduct clinical trials, and submit drug applications for their prescription portfolio.

Company
Stratus Pharmaceuticals Inc
Inspection date
December 8, 2014
Product type
OTC (Over-the-Counter)
Office
Florida District Office
People
  • Ileana Barreto-Petit
  • Richard A. Lyght
View Company Profile

ID · a33f1c74-b2e2-41a9-a7ef-d0fa73ded479

Violation Codes7
21 CFR 820.19821 CFR 21121 CFR 211.198(a)21 CFR 314.8021 CFR 211.25(a)21 CFR 314.9821 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

Other documents for Stratus Pharmaceuticals Inc
  • EIR - 2018-03-08March 8, 2018
  • 483 - 2014-12-08December 8, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Stratus Pharmaceuticals Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.